Standalone | Consolidated | |||
---|---|---|---|---|
Particulars | FY 2022 | FY 2021 | FY 2022 | FY 2021 |
Debtors Turnover ratio | 51.43 | 69.63 | 88.0.3 | 90.92 |
Inventory turnover ratio | 59.06 | 62.88 | 204.22 | 224.18 |
Interest Coverage ratio | 1.86 | 1.18 | 1.45 | 1.73 |
Current ratio | 1.06 | 0.78 | 1.30 | 1.49 |
Debt Equity ratio | 0.25 | 0.25 | 1.31 | 0.99 |
Operating Profit Margin (%) | ||||
Pharmaceuticals | 4.81 | 4.12 | 18.00 | 22.21 |
Financial Services | 29.28 | 16.47 | 22.22 | 34.13 |
Normalised Net profit margin ratio (%) | 26.17 | 7.07 | 20.24 | 19.88 |
Return on Net worth (%) | 2.52 | 0.56 | 7.98 | 7.49 |
Following are reasons for the movement in key ratios:
(` Crores)
Profit and Loss Account | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 |
Revenue from Operations | 3,544 | 4,503 | 5,123 | 6,381 | 8,547 | 10,639 | 11,883 | 13,068 | 12,809 | 13,993 |
EBITDA | 611 | 860 | 1,140 | 1,929 | 3,733 | 5,419 | 7,175 | 6,758 | 7,828 | 7,170 |
Interest | 575 | 1,050 | 511 | 959 | 2,031 | 2,978 | 4,100 | 5,321 | 4,209 | 4,480 |
Profit Before Tax | (193) | (435) | 3,035 | 954 | 1,480 | 2,244 | 2,675 | 918 | 3,058 | 2,025 |
Profit After Tax2 | (227) | (501) | 2,850 | 905 | 1,252 | 5,120 | 1,464 | 21 | 1,413 | 1,999 |
Normalised Profit3 | (227) | (501) | 421 | 905 | 1,252 | 1,551 | 2,142 | 2,615 | 2,627 | 2,908 |
Earnings per share2 (` only) | (13) | (29) | 165 | 52 | 73 | 281.8 | 72.2 | 1.14 | 56.19 | 80.70 |